Announced Fri, 3 Jul · 19:03 IST
CEO transition at Bliss GVS Pharma; new director appointed
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.6%1-day move
₹504.00
prior close
₹505.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7+1.4+0.7+0.4+0.6+0.9+4.5+4.2+5.2+2.2-9.4———
Up moveDown movePending
AI summary
Bliss GVS Pharma announced three board changes effective July 2026. Mr. Santosh Parab, a Chartered Accountant with 35 plus years experience in audit, taxation and corporate finance, joins as Non-Executive Director from July 3, 2026. Mr. Rahul Adakmol, an IIM Bangalore graduate with 22 plus years experience at Bharat Serums, Dr Reddy's and Reliance, will take over as CEO from July 15, 2026. Current CEO Mr. Narsimha Kamath steps down from the CEO role on July 14, 2026 but will continue as Managing Director.
Likely market impact
Leadership transition with seasoned external CEO and new director. Kamath stays on as MD, ensuring continuity.